Andrew is responsible for the overall strategy and performance of the business. He works closely with the team to support our clients and healthcare data providers.
Previously, he was the SVP of Healthcare Value Solutions for IMS Health. Health Economics and Outcomes Research Services, Real World Evidence Solutions, Payer and Provider Services, Clinical Trial Optimization Solutions, and Government Services were among the organizations reporting to Andrew. In addition, he created the company’s mobile health offerings and designed their emerging genomics strategy.
Prior to IMS, Andrew was the CEO of SDI Health—the recognized leader in clinical and transactional healthcare data-based analytics—prior to its acquisition by IMS Health in 2011. During his tenure, SDI developed and grew one of the largest linked de-identified healthcare data assets available. SDI also became the nation’s second largest pharmaceutical informatics concern, with over 600 employees servicing hundreds of clients. Andrew’s track record at SDI included multiple strategic acquisitions that enabled the company to continuously drive growth and shareholder value.
He is also involved as an investor and advisor to a number of other healthcare start-ups.
Andrew holds a B.A. in English from Yale University.